Plain-English translation of NCT06681363 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Nantes University Hospital are building a collection of blood and bone marrow samples from patients with certain types of blood cancer—including acute myeloid leukemia, acute lymphoid leukemia, and high-risk myelodysplastic syndrome. By studying these samples, scientists hope to find new genetic clues and identify targets for better treatments in the future.
Currently, doctors don't fully understand all the factors that cause these blood cancers to develop or how best to treat them. This research collection will help scientists discover new biomarkers and therapeutic targets that could lead to more effective treatments for patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, doctors will collect extra blood and bone marrow samples during your regular medical visits—no additional needle sticks beyond what you're already receiving as part of your care. At the time you join, samples will be taken during your diagnostic visit or at relapse. Researchers may then ask for up to one additional sample per month for three months if they need more material to complete their studies. The samples will be stored and analyzed to look for genetic patterns and new treatment targets.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Sponsor
Nantes University Hospital
Enrollment target
~1,000 participants
Started
May 2026
Primary completion
May 2036
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pierre Perterlin
Nantes University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.